Citations

Showing 10 of 108135 citations.

Lung Transplantation in Systemic Sclerosis: a Practice Survey of United States Lung Transplant Centers
Sehgal, Sameep , Pennington, Kelly M. , Kennedy, Cassie C. , Kennedy, Cassie C , Zhao, Huaqing

Mayo Clinic

Transplantation Direct | September 8, 2021 | Volume: 7 | Issue: 10 | Pages: e757

10.1097/txd.0000000000001209 | PMID 34514112 Get It

Background. Lung transplantation in patients with systemic sclerosis (SSc) can be complicated by extrapulmonary manifestations of the disease, leading to concerns regarding posttransplant complications and outcomes. Methods. We conducted a web-based survey of adult lung transplant programs in the United States regarding their practices in patients with SSc. Results. Sixty percent (37/62) of the eligible centers responded to the survey, majority of the respondents were medical directors (81%). Most centers would consider transplanting patients with mild or moderate esophageal disease (92% or 75%, respectively) or gastroparesis (59%). A minority would consider patients with severe esophageal dysmotility (37%), digital ulcers (21%), or low body mass index (19%). Most centers conducted extensive pretransplant gastrointestinal evaluation and use a conservative feeding approach with prolonged nothing by mouth (83%) and postpyloric feeding (89%). Antireflux surgery is commonly considered (40%) with partial fundoplication being the procedure of choice (67%). Most respondents expected similar outcomes of acute or chronic rejection (81% and 51%, respectively), respiratory infections (76%), and 1-year survival (70%). Conclusions. Most US lung transplant centers do not universally exclude SSc from lung transplant listing, but most support extensive pretransplant gastrointestinal testing and a conservative approach to feeding in the early posttransplant period.
Astrocytes in the external globus pallidus coordinate flexibility of action strategy
Yang, Minsu Abel , Kang, Shinwoo , Lee, Jeyeon , Choi, Doo‐Sup , Choi, Doo-Sup , Hong, Sa‐Ik , Kang, Seungwoo , Song, Minryung , Baker, Matthew , Lee, Sang Wan

Mayo Clinic

No container title available | September 8, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-845991/v1 Get It

Abstract The external globus pallidus (GPe) is an integrative hub and gateway for behavioral flexibility in reward-related behaviors. However, it remains unknown whether enriched astrocytes in the GPe guide behavioral flexibility. Here, we trained mice to exhibit goal-directed and habitual reward-seeking behaviors using the behavior tasks with effort- and time-based reward delivery, respectively. Then, we examined the temporal dynamics of GPe astrocytes during goal-directed and habitual learning. Overall, GPe astrocytes were substantially silenced during habitual learning compared to goal-directed learning. In the timescale of action events, GPe astrocyte activities were increased immediately after termination of reward-taking behavior before the following action. However, during habitual learning, the increase of astrocyte activity was not evident. Moreover, support vector machine (SVM) analysis demonstrated that GPe astrocytes dynamics predicted whether mice perform goal-directed or habitual behaviors. Interestingly, chemogenetic activation of GPe astrocytes, which dampened GPe neuronal firings and habitual behaviors, exhibting goal-directed behaviors. Strikingly, brief and repeated attentional stimulations recapitulated the effect of chemogenetic activation of GPe in intervening the habitual reward-seeking behaviors with increased GPe astrocyte activities. Our findings reveal a novel insight that increasing GPe astrocytic activities attenuates habitual behavior and improves behavioral flexibility, which may provide a potential therapeutic target for decision-making-related disorders, such as obsessive-compulsive disorder and addiction.
Research methodologies to address clinical unmet needs and challenges in alcohol‐associated liver disease
Singal, Ashwani K. , Kwo, Paul Y. , Kwong, Allison J. , Liangpunsakul, Suthat , Louvet, Alexandre , Mellinger, Jessica L. , Terrault, Norah A. , Thursz, Mark , Kim, W. Ray , Shah, Vijay H. , Mellinger, Jessica , Terrault, Norah , Winder, Scott , Louvet, Alexandre , Singal, Ashwani K , Kwong, Allison , Kwo, Paul Y , Mandrekar, Pranoti , McClain, Craig J. , Szabo, Gyongyi , Winder, Gerald Scott

Mayo Clinic

Hepatology | September 8, 2021 | Volume: 75 | Issue: 4 | Pages: 1026-1037

10.1002/hep.32143 | PMID 34496071 Get It

Abstract Alcohol‐associated liver disease (ALD) is emerging worldwide as the leading cause of liver‐related morbidity, mortality, and indication for liver transplantation. The ALD Special Interest Group and the Clinical Research Committee at the digital American Association for the Study of Liver Diseases meeting in November 2020 held the scientific sessions to identify clinical unmet needs in ALD, and addressing these needs using clinical research methodologies. Of several research methodologies, the sessions were focused on (a) studying disease burden of ALD using large administrative databases, (b) developing biomarkers for noninvasive diagnosis of alcohol‐associated hepatitis (AH) and estimation of disease prognosis, (c) identifying therapeutic targets for ALD and AH, (d) deriving accurate models to predict prognosis or posttransplant alcohol relapse as a basis for developing treatment algorithm and a uniform protocol on patient‐selection criteria for liver transplantation, and (e) examining qualitative research methodologies in studying the barriers to implementation of multidisciplinary integrated care model by hepatology and addiction teams for the management of dual pathology of liver disease and of alcohol use disorder. Prospective multicenter studies are required to address many of these clinical unmet needs. Further, multidisciplinary care models are needed to improve long‐term outcomes in patients with ALD.
Times Are a Changin’: Marijuana Use among Plastic Surgery Patients
Teven, Chad M. , Song, David

Mayo Clinic

Plastic & Reconstructive Surgery | September 8, 2021 | Volume: 148 | Issue: 4 | Pages: 702e-704e

10.1097/prs.0000000000008380 | PMID 34495898 Get It

Improving Family-Building Support and Fertility Care Access
Kelly, Amelia G. , Levy, Morgan S. , Brown, Alyssa

Mayo Clinic

Academic Medicine | September 8, 2021 | Volume: 97 | Issue: 7 | Pages: 949-949

10.1097/acm.0000000000004389 | PMID 34495883 Get It

Addressing the Elephant in the Intensive Care Unit: The Role of Interprofessional Education
Gary, Phillip , Niven, Alexander S. , Niven, Alexander S , Dong, Yue

Mayo Clinic

ATS Scholar | September 8, 2021 | Volume: 2 | Issue: 3 | Pages: 293-296

10.34197/ats-scholar.2021-0100ed | PMID 34667978 Get It

Acute Ischemic Priapism: An AUA/SMSNA Guideline
Bivalacqua, Trinity J. , Allen, Bryant , Brock, Gerald, Köhler, Tobias , Mulhall, John P. , Oristaglio, Jeff, Rahimi, Leila L., Rogers, Zora R. , Terlecki, Ryan , Trost, Landon , Yafi, Faysal A. , Bennett, Nelson , Broderick, Gregory A.

Mayo Clinic

Journal of Urology | September 8, 2021 | Volume: 206 | Issue: 5 | Pages: 1114-1121

10.1097/ju.0000000000002236 | PMID 34495686 Get It

Clinicopathologic Characteristics, Treatment, and Outcomes of Post-transplant Lymphoproliferative Disorders: A Single-institution Experience Using 2017 WHO Diagnostic Criteria
King, Rebecca L. , Khurana, Arushi , Mwangi, Raphael , Ristow, Kay M., Macon, William R. , Ansell, Stephen M. , Kudva, Yogish C. , Walker, Randall C., Watt, Kymberly D. , Schwab, Thomas R., Kushwaha, Sudhir S. , Famà, Angelo , Maurer, Matthew J. , Bennani, N. Nora , Cerhan, James R. , Habermann, Thomas M.

Mayo Clinic

HemaSphere | September 8, 2021 | Volume: 5 | Issue: 10 | Pages: e640

10.1097/hs9.0000000000000640 | PMID 34514344 Get It

The World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues (WHO 2017) included updated criteria for diagnosis and classification of post-transplant lymphoproliferative disorders (PTLDs). This study evaluated the clinicopathologic spectrum using WHO 2017 criteria and adult PTLD patients’ outcomes over 30 years between 1987 and 2017 at Mayo Clinic (Rochester, MN). Patients were retrospectively reviewed for clinical features, outcomes, and diagnostic pathology material and classified based on WHO 2017 criteria. A total of 227 patients were diagnosed with PTLD, with a median time from transplant to PTLD of 45 months. PTLD occurred >1 year after transplant in 149 (66%) patients. Monomorphic PTLD was the most common subtype (173, 76%), with diffuse large B cell lymphoma as the commonest morphology (n = 137). Epstein-Barr virus was positive in 61% of total cases and 90% of PTLD that developed within 1 year from transplant. The median event-free survival (EFS) and overall survival for the entire cohort were 21 months (95% confidence interval [CI]: 9–35) and 82 months (95% CI: 39–115), respectively. The EFS or overall survival was not impacted by Epstein-Barr virus status but differed based on WHO subtypes and year of diagnosis. Management changed over time with increased use of rituximab or chemotherapy + immunosuppression reduction as initial therapy. When compared to the matched general population and de novo diffuse large B cell lymphoma, patients not achieving EFS 24 status (no progression/treatment or death within 24 mo of diagnosis) had a worse standardized mortality ratio 16.75 (95% CI: 13.91–20) versus SMR 1.72 (95% CI: 1.26–2.28) in those who achieved EFS24. Cause of death was mostly attributed to non-lymphoma–related causes in those achieving EFS 24.
Macromastia as a Cause of Chronic Back Pain
Layon, Sarah A. , Pflibsen, Lacey R. , Maasarani, Samantha , Noland, Shelley S.

Mayo Clinic

Journal of Women's Health | September 8, 2021 | Volume: 30 | Issue: 10 | Pages: 1372-1374

10.1089/jwh.2021.0405 | PMID 34495757 Get It

Faculty Opinions recommendation of Pirfenidone in heart failure with preserved ejection fraction: a randomized phase 2 trial.
Borlaug, Barry A.

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | September 8, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.740634987.793588044 Get It